Clinical Trial Update: Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents [Phase 2]

View source ↗

Summary

Phase 2 investigational device exemption trial assessing safety and efficacy of Astron and Pulsar stents; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• Astron Stent
• Pulsar stent (Pulsar)

Snippet

Sponsor: Biotronik, Inc. | Conditions: Peripheral Artery Disease, Peripheral Vascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-06-05